65,437 trials
Onychomycosis
Primary: Non-inferiority Will be Determined by Evaluating the Difference Between the Proportion of Patients in the Test and Reference Treatment Groups Who Are Considered a…
Headache
Primary: Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. — 25; 25 Participants
Paraplegia
Primary: Count to Achieve Mobility Skills — 9; 3; 0; 10 Participants
Tobacco Smoking
Primary: Intervention Feasibility: Participant Attendance — 6.30; 8.71 Sessions
Renal Impairment · Healthy Volunteers
Primary: Groups A, C and D; Cmax: Maximum Observed Plasma Concentration for TAK-954 (Total and Free) — 2.623; 2.536; 2.660; 0.1270 nanogram per milliliter (ng/mL) — p=0.7265
Sarcoma, Soft Tissue
Primary: Tumor Best Response Rate — 0 Participants
Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns
Primary: Survival at One Year — 16; 17 Participants
Breast Cancer
Primary: Number of Patients With Any Toxicity Related to the Radiation Treatment — 40 Participants
Overweight · Obese
Primary: Slope of Body Mass Index (BMI) — 0.821; 1.083; 0.952 kg/m^2/year
Migraine Disorders
Primary: Number of Participants With at Least 1 Treatment Emergent Adverse Event — 447; 545 Participants
Amyotrophic Lateral Sclerosis
Primary: Number of Subjects With Improved Respiratory Symptoms as Shown by Chest X-Ray Between Baseline and End of Study — 0; 0 Participants
Osteoarthritis
Primary: Change From Baseline to Month 4 for Minutes of Moderate to Vigorous Intensity PA Per Week — 0.78 minutes — p=0.5145
Thyroid Cancer
Primary: Number of Participants With Response Per Responsive Evaluation Criteria in Solid Tumors Criteria (RECIST v1.0) — 17; 9; 11 Participants
Delayed Emergence From Anesthesia
Primary: Extubation Time — 9.5; 6.2 minutes
Anesthesia
Primary: Intraocular Pressure (IOP) — 18; 16; 19; 16 mmHg